Global Anti-inflammatory Agents Market Growth (Status and Outlook) 2024-2030

Global Anti-inflammatory Agents Market Growth (Status and Outlook) 2024-2030

Anti-inflammatory agents block certain substances in the body that cause inflammation. They are used to treat many different conditions such as treat migraines, headaches, rheumatic arthritis, sprains, and menstrual pain. Furthermore, some anti-inflammatory agents such as celecoxib and ibuprofen are being studied for the prevention and treatment of cancer. In addition, they can provide faster relief as compared to other drugs. They are capable of lowering the levels of prostaglandins and the chemicals responsible for inflammation, thereby reducing pain and swelling. Anti-inflammatory drugs usually target the anti-inflammatory mediators or enzymes. These drugs are often used in combination of other drugs. Inflammation is the most prevalent treatable symptom among many immune and respiratory diseases.

The global Anti-inflammatory Agents market size is projected to grow from US$ 100020 million in 2024 to US$ 127650 million in 2030; it is expected to grow at a CAGR of 4.1% from 2024 to 2030.

LPI (LP Information)' newest research report, the “Anti-inflammatory Agents Industry Forecast” looks at past sales and reviews total world Anti-inflammatory Agents sales in 2022, providing a comprehensive analysis by region and market sector of projected Anti-inflammatory Agents sales for 2023 through 2029. With Anti-inflammatory Agents sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Anti-inflammatory Agents industry.

This Insight Report provides a comprehensive analysis of the global Anti-inflammatory Agents landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Anti-inflammatory Agents portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Anti-inflammatory Agents market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Anti-inflammatory Agents and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Anti-inflammatory Agents.

The growth of the global anti-inflammatory agents market has been driven by factors such as increase in prevalence of autoimmune & respiratory conditions, new drugs in pipeline, and surge in adoption of anti-inflammatory drugs. Furthermore, the demand for anti-inflammatory drugs has been increasing exponentially, owing to the emergence of anti-inflammatory biologics that are more targeted, effective, and with lesser side effects as compared to conventional drugs. Moreover, rise in awareness of anti-inflammatory therapeutics and attractive government initiatives toward the treatment of inflammation with nonsteroidal anti-inflammatory drugs in Asia-Pacific and LAMEA are expected to drive the market growth during the analysis period. However, factors such as side effects of anti-inflammatory drugs and patent expiry issues of blockbuster drugs (such as Remicade) impede the market growth.

This report presents a comprehensive overview, market shares, and growth opportunities of Anti-inflammatory Agents market by product type, application, key players and key regions and countries.

Segmentation by Type:
Software
Services

Segmentation by Application:
Pharmaceutical and Biotechnology Companies
Contract Research and Development Organizations
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

Segmentation by Type:
Software
Services

Segmentation by Application:
Pharmaceutical and Biotechnology Companies
Contract Research and Development Organizations
Others

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Thermo Fisher Scientific Inc
Oracle Corporation
Revvity, Inc
Clario
Illumina, Inc
Qiagen NV
Agilent Technologies, Inc
IBM Corporation
Genedata AG
DNAnexus, Inc

Please note: The report will take approximately 2 business days to prepare and deliver.